The Gardens at Millville violated federal medication management requirements throughout September and October 2025, according to a complaint inspection completed October 15. Staff signed out Ativan doses from the facility's controlled substance accounting system but left the corresponding medication administration records blank.
The violations involved multiple doses of Ativan 0.5 mg prescribed for Resident 3. Nursing staff documented removing the controlled substance from secure storage on at least 16 separate occasions in September, including doses given at 1:00 PM on September 1, 12:00 PM on September 2, and continuing through September 30 at 11:45 PM.
None of those doses appeared on the resident's official medication administration record for September.
The pattern continued into October. Staff signed out three more Ativan doses from the controlled substance log on October 5 at 8:00 AM, October 10 at 9:00 AM, and October 12 at midnight. Again, the facility's medication administration records showed no documentation that the resident actually received the anti-anxiety medication.
The Director of Nursing confirmed the discrepancies during an interview with state inspectors on October 15 at 4:00 PM. The nursing supervisor acknowledged that doses were documented as given on the narcotic reconciliation record but were not signed out as administered on the required medication administration forms.
Federal regulations require nursing homes to maintain accurate medication records to ensure residents receive prescribed treatments and prevent dangerous drug interactions or overdoses. The dual documentation system serves as a critical safety check, with controlled substance logs tracking removal from secure storage and medication administration records confirming actual delivery to patients.
The violations at Gardens at Millville created a scenario where anti-anxiety medication disappeared from the facility's controlled substance inventory without corresponding proof that residents received their prescribed doses. This gap makes it impossible to verify whether patients got needed medications or whether doses were diverted, lost, or administered incorrectly.
Ativan, the brand name for lorazepam, is a controlled substance used to treat anxiety and panic disorders in elderly patients. The medication requires careful monitoring due to its potential for dependence and serious side effects, particularly in seniors who may experience increased confusion, falls, or breathing problems.
The inspection focused specifically on Resident 3's medication management but did not indicate whether similar documentation failures affected other patients at the 120-bed facility. The violation was classified as causing minimal harm or potential for actual harm to some residents.
State inspectors cited the facility under federal tag F755, which governs pharmacy services and requires nursing homes to maintain accurate medication administration records. The citation also referenced multiple sections of Pennsylvania nursing home regulations covering nursing services, pharmacy operations, and resident care policies.
The facility's medication administration failures occurred during a two-month period when staff should have been following established protocols for controlled substance management. Each missing signature on the medication administration record represented a breakdown in the facility's safety systems designed to protect vulnerable residents.
Gardens at Millville operates as a skilled nursing and rehabilitation center in Columbia County. The facility has faced previous regulatory scrutiny, though the scope of this latest violation suggests ongoing challenges with basic medication management procedures that form the foundation of safe nursing home care.
The inspection report did not detail what corrective actions the facility planned to implement or whether additional residents were affected by similar documentation gaps. The violation remains unresolved, with the potential for federal fines or other enforcement actions depending on the facility's response to the citation.
For Resident 3, the documentation failures meant weeks of uncertainty about whether prescribed anti-anxiety medication was actually administered during a period when accurate dosing would have been critical for managing anxiety symptoms and maintaining quality of life.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Gardens At Millville, The from 2025-10-15 including all violations, facility responses, and corrective action plans.